Noguchi calls for monthly disinfection of facilities LISTEN
FEB 5, 2021
A Senior Research Fellow at the Immunology Department of Noguchi Memorial Institute for Medical Research (NMIMR), Dr Kwadwo Asamoah, has made a passionate appeal to waste management and disinfection experts, Zoomlion Ghana Limited (ZGL), for a monthly disinfection of the facility.
Such a move, he stressed, will help safeguard the facility and its environment for use by staff members and the general public against Covid-19.
He made the appeal on Friday, February 5, 2021, when Zoomlion disinfected the research facility which since the country recorded its first cases of Covid has been supporting the government to fight the disease.
9 Uniformed Services University (USU) researchers working on a new gamma radiation vaccine development platform have been recognized for their efforts, earning the prestigious 2021 Federal Laboratory Consortium’s (FLC) Award for Technology Transfer.
The FLC is the congressionally-mandated organization that educates, promotes, and facilitates federal technology transfer. The Excellence in Technology Transfer Award is presented annually to lab employees, representing more than 300 federal labs supported by the FLC, who have accomplished outstanding work in the process of transferring federally-developed technology.
Dr. Michael J. Daly, professor of Pathology at USU, was recently selected for the FLC Tech Transfer Award for his work “Novel Vaccine Production Using Unique Technology Derived from Radiation-resistant Bacteria.” As part of this research, in collaboration with BMI, Inc., Daly and his colleagues were able to successfully apply a powerful manganese (Mn
Israeli virus experts: We may need vaccine updates every year or two | US & World News jewishaz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishaz.com Daily Mail and Mail on Sunday newspapers.
Israeli virus experts: ‘We may need vaccine updates every year or two’
Israeli virus experts: ‘We may need vaccine updates every year or two’
While COVID-19 has the potential to evolve rapidly, “the good news is that it is very easy to create this vaccine,” said Tel Aviv University doctors, adding that these inoculations are far more effective than flu vaccinations.
(January 20, 2021 / JNS) In the coming years, pharmaceutical corporations will likely need to launch updated versions of their coronavirus vaccines every year or two years, though this task should not present any special challenges for them, leading Israeli virus experts from Tel Aviv University have said. In addition, a two-dose vaccine is “highly likely” to offer good protection against the current variants in circulation in the world, they assessed.
Danaher Announces Executive Appointment
Share this article
Share this article
WASHINGTON, Dec. 21, 2020 /PRNewswire/ Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ( JC ) Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher. In this role, Dr. Gutierrez-Ramos will have responsibility for helping define Danaher s science and technology strategy across the organization, including facilitating innovation and further development of scientific and technology talent. With this appointment, Dr. Gutierrez-Ramos will become an executive officer of the Company and report directly to Rainer M. Blair, President and Chief Executive Officer.
Mr. Blair stated, JC brings tremendous scientific and technological expertise to Danaher. The depth of his experience combined with his innovation leadership will be important contributions as we continue to build a stronger, better Danaher. We are excited to welcome JC to the Danaher team.